King Acquires Elan’s US Primary Care Business
By Business Review Editor
Pharma Deals Review: Vol 2003 Issue 33 (Table of Contents)
Published: 3 Feb-2003
DOI: 10.3833/pdr.v2003.i33.936 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
King Pharmaceuticals signed an agreement worth US$935 M with Elan to acquire Elan’s primary care business unit in US and Puerto Rico...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS